Delivery Order SPE2DX22D0029-SPE2D825F40DD
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation and will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $42,979.58 to AmerisourceBergen Drug Corp on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contracting vehicle serves as a...
- The U.S. Defense Department's Medical Supply Chain division awarded a delivery order valued at $72,647.06 to AmerisourceBergen Drug Corp on August 3, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The contract will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $58,103.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of the same day. This competitive, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,634.38 to AmerisourceBergen Drug Corp on August 11, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was competitively procured with no set-aside designation and will be performed at the contractor's corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on July 29, 2025, with a ceiling value of $1,192.02 and an ultimate completion date of July 30, 2025. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award is firm fixed price, non-competitive set-aside, and will...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $20,049.12 by the Defense Logistics Agency's Medical Supply Chain on April 10, 2025, with completion scheduled for April 11, 2025. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $475,352.28 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $27,999.27 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The company serves as a critical pharmaceutical distributor for federal medical...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D825F40DDDelivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on August 18, 2025, for an amount of $39,640.32 under a firm fixed-price contract. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract is scheduled for completion by August 19, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies and pharmaceutical products to federal military and veteran healthcare systems. Under its prime IDC vehicle, the company supplies a comprehensive portfolio including brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical devices across multiple therapeutic domains to support Defense Health Agency and broader military healthcare operations. This delivery order represents one of numerous competitively awarded transactions under the larger pharmaceutical support framework, demonstrating the contractor's ongoing capacity to meet federal medical procurement requirements on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.6k | 8/18/25 |